Literature DB >> 32258578

Satisfaction with a therapeutic sleeve for arm lymphedema secondary to breast cancer treatment: Controlled crossover trial.

F Osório1, L Ferro1, L Garrido1, A Henriques2, J Cruz3, R Fangueiro3, J L Fougo1, A Azevedo2,4,5.   

Abstract

HIGHLIGHTS: Secondary lymphedema is a late iatrogenic side effect of breast cancer treatment.Despite multimodal decongestive therapy in their daily life breast cancer survivors with lymphedema have few alternatives but to use a compressive sleeve.Concerned with the well-known low compliance to the daily use of traditional sleeves, we conducted a comparative study to evaluate the subjective assessment of an innovative class 1 compression sleeve.We concluded that the PRADEX® sleeve, not being worse in its compressive efficacy, is much better with regard to patient comfort. ABSTRACT: Secondary arm lymphedema is a feared late iatrogenic side effect of breast cancer survivors with a negative impact on patient's self-image and quality of life. Its reported incidence is extremely variable, from 6% to 80%, as well as the effectiveness of the multimodal decongestive lymphedema therapy.In their daily life breast cancer survivors with lymphedema have few alternatives but to use a compressive sleeve. Concerned with the well-known low compliance to the daily use of traditional sleeves, we conducted a comparative study in a subgroup of our patients with lymphedema secondary to breast cancer treatment for the subjective assessment of PRADEX®, an innovative class 1 compression sleeve. Secondarily, we aimed to assess the non-inferiority of PRADEX® regarding subjective and objective measures of the severity of lymphedema.We studied 46 women with grade 1 secondary arm lymphedema, who used their usual sleeve and PRADEX® daily for 2 weeks each, in a crossover design.The new therapeutic sleeve was classified as having a better design and a better usability and comfort (more comfortable, thinner, fresher, softer, more flexible, comfortable, resistant to dirt and easier to dress and to wear). Women's subjective opinion about the severity of lymphedema favored their usual sleeve in detriment of PRADEX®, but this subjective feeling was contradicted by objective measurements of different perimeters of the arm at the beginning and at the end of the study.We concluded that the PRADEX® sleeve, not being worse in its compressive therapeutic efficacy, is much better with regard to patient comfort. Copyright 2016 PBJ-Associação Porto Biomedical/Porto Biomedical Society.

Entities:  

Keywords:  Breast cancer; Compression elastic sleeve; Secondary lymphedema

Year:  2016        PMID: 32258578      PMCID: PMC6806987          DOI: 10.1016/j.pbj.2016.11.005

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN: 2444-8664


  10 in total

Review 1.  The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2013-03       Impact factor: 1.286

Review 2.  Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review.

Authors:  Nele Devoogdt; Marijke Van Kampen; Inge Geraerts; Tina Coremans; Marie-Rose Christiaens
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-12-16       Impact factor: 2.435

3.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults.

Authors: 
Journal:  Am J Clin Nutr       Date:  1998-10       Impact factor: 7.045

Review 4.  A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011.

Authors:  Bonnie B Lasinski; Kathryn McKillip Thrift; Decourcy Squire; Melanie K Austin; Kandis M Smith; Ausanee Wanchai; Jason M Green; Bob R Stewart; Janice N Cormier; Jane M Armer
Journal:  PM R       Date:  2012-08       Impact factor: 2.298

Review 5.  Lymphedema.

Authors:  S G Rockson
Journal:  Am J Med       Date:  2001-03       Impact factor: 4.965

6.  Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.

Authors:  Cynthia L Miller; Michelle C Specht; Melissa N Skolny; Nora Horick; Lauren S Jammallo; Jean O'Toole; Mina N Shenouda; Betro T Sadek; Barbara L Smith; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2014-02-06       Impact factor: 4.872

7.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

8.  Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit.

Authors:  Hiba A Bani; Peter A Fasching; Michael M Lux; Claudia Rauh; Michaela Willner; Irina Eder; Christian Loehberg; Michael Schrauder; Matthias W Beckmann; Mayada R Bani
Journal:  Patient Educ Couns       Date:  2007-02-27

9.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Authors:  Anthony Lucci; Linda Mackie McCall; Peter D Beitsch; Patrick W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukumal Saha; Kelly K Hunt; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

Review 10.  Lymphedema following treatment for breast cancer: a new approach to an old problem.

Authors:  Jean O'Toole; Lauren S Jammallo; Melissa N Skolny; Cynthia L Miller; Krista Elliott; Michelle C Specht; Alphonse G Taghian
Journal:  Crit Rev Oncol Hematol       Date:  2013-06-16       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.